Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,687 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intratracheal and oral administration of SM-276001: a selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer.
Koga-Yamakawa E, Dovedi SJ, Murata M, Matsui H, Leishman AJ, Bell J, Ferguson D, Heaton SP, Oki T, Tomizawa H, Bahl A, Takaku H, Wilkinson RW, Harada H. Koga-Yamakawa E, et al. Among authors: harada h. Int J Cancer. 2013 Feb 1;132(3):580-90. doi: 10.1002/ijc.27691. Epub 2012 Jul 11. Int J Cancer. 2013. PMID: 22733292
TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice.
Koga-Yamakawa E, Murata M, Dovedi SJ, Wilkinson RW, Ota Y, Umehara H, Sugaru E, Hirose Y, Harada H, Jewsbury PJ, Yamamoto S, Robinson DT, Li CJ. Koga-Yamakawa E, et al. Among authors: harada h. Cancer Immunol Immunother. 2015 Oct;64(10):1229-39. doi: 10.1007/s00262-015-1730-4. Epub 2015 Jun 20. Cancer Immunol Immunother. 2015. PMID: 26091797 Free PMC article.
Birth weight and head circumference for 22-29 weeks gestation neonates from an international cohort.
Fenton TR, Alshaikh B, Kusuda S, Helenius K, Modi N, Norman M, Lui K, Lehtonen L, Battin M, Klinger G, Vento M, Lastrucci V, Gagliardi L, Adams M, Marba STM, Isayama T, Hakansson S, Bassler D, Shah PS; International Network for Evaluation of Outcomes (iNeo) of Neonates Investigators. Fenton TR, et al. Arch Dis Child Fetal Neonatal Ed. 2025 Jan 6:fetalneonatal-2024-327845. doi: 10.1136/archdischild-2024-327845. Online ahead of print. Arch Dis Child Fetal Neonatal Ed. 2025. PMID: 39762001
Health Utility of Pain Response Versus Nonresponse to Palliative Radiation Therapy for Symptomatic Bone Metastases: Analyses Based on Real-World Data from 26 Centers.
Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, Notsu A, Shirato H, Yamada K, Uezono H, Koide Y, Kubota H, Yamazaki T, Ito K, Heianna J, Okada Y, Tonari A, Katoh N, Wada H, Ejima Y, Yoshida K, Kosugi T, Takahashi S, Komiyama T, Uchida N, Miwa M, Watanabe M, Nagakura H, Ikeda H, Asakawa I, Shigematsu N. Saito T, et al. Among authors: harada h. J Palliat Med. 2024 Dec 27. doi: 10.1089/jpm.2024.0208. Online ahead of print. J Palliat Med. 2024. PMID: 39729365
The potential role of chromodomain helicase DNA-binding protein 3 in defining the cervical width by regulating the early growth stage of the apical papilla during tooth development.
Shimamura K, Nojiri T, Kondo H, Ikeda Y, Yasuhara R, Ida-Yonemochi H, Otsu K, Harada H, Mishima K, Ohshima H, Kobayashi T, Irié T. Shimamura K, et al. Among authors: harada h. J Oral Biosci. 2024 Dec 20:100604. doi: 10.1016/j.job.2024.100604. Online ahead of print. J Oral Biosci. 2024. PMID: 39710094 Free article.
Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort study.
Horinouchi H, Murakami H, Harada H, Sobue T, Kato T, Atagi S, Kozuki T, Tokito T, Oizumi S, Seike M, Ohashi K, Mio T, Sone T, Iwao C, Iwane T, Koto R, Tsuboi M. Horinouchi H, et al. Among authors: harada h. Lung Cancer. 2024 Nov 14;199:108027. doi: 10.1016/j.lungcan.2024.108027. Online ahead of print. Lung Cancer. 2024. PMID: 39708388 Free article.
Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.
Uryu K, Imamura Y, Shimoyama R, Mase T, Fujimura Y, Hayashi M, Ohtaki M, Otani K, Hibino M, Horiuchi S, Fukui T, Fukai R, Chihara Y, Iwase A, Yamada N, Tamura Y, Harada H, Tsuya A, Okabe T, Fukuoka M, Minami H. Uryu K, et al. Among authors: harada h. Jpn J Clin Oncol. 2024 Dec 1:hyae167. doi: 10.1093/jjco/hyae167. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39673402
2,687 results